BioCentury
ARTICLE | Clinical News

Bioniche Inc. preclinical data

August 2, 1999 7:00 AM UTC

BNC reported that MCC inhibited the division of both androgen-dependent and androgen-independent malignant human prostate tumor cells. Inhibition of tumor cell division was associated with induction of apoptosis and decreased prostate-specific antigen production. Results were presented at the British Cancer Research Meeting in Edinburgh. ...